Joke H de Boer (Joke de Boer)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Atopic Dermatitis

Peritoneal Dialysis

Patient Reported

Top Venues

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2022)
Roselie E Achten, Daphne S Bakker, Chantal M van Luijk, M Marlot van der Wal, Marlies de Graaf, Femke van Wijk, Nicolaas P A Zuithoff, Lisa P van der Rijst, Celeste M Boesjes, Judith L Thijs, Joke H de Boer, Marjolein de Bruin-Weller
Ocular surface disease is common in moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 52 (6) (2022)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 53 (2) (2022)
Roselie E Achten, Judith L Thijs, Chantal van Luijk, Edward F Knol, Eveline Delemarre, Marlies de Graaf, Daphne S Bakker, Joke H de Boer, Femke Van Wijk, Marjolein de Bruin-Weller
Biomarkers in tear fluid of dupilumab-treated moderate-to-severe atopic dermatitis patients. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 53 (2) (2022)